drugset / Trial / NCT04002362
Symptom Clusters in Children With Exacerbation-prone Asthma
Phase 2
Completed
68 enrolled
Emory University
National Institute of Nursing Research (NINR) · collab
NaSingle-groupOpen-labelTreatment
Summary
Pediatric participants with exacerbation-prone asthma will receive an intramuscular injection of triamcinolone acetonide and will be followed for 48 weeks. The study visit 2 weeks after the injection will assess the response to the study medication, while the remaining study visits will examine the temporal stability of the symptom clusters.
Timeline
- Start
- 2019-11-13
- Primary completion
- 2025-01-16
- Completion
- 2025-12-24
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Triamcinolone Acetonide | Other / unclassified | 1 mg/kg | Intramuscular |